130 related articles for article (PubMed ID: 10704736)
1. Demonstration of MDR1 P-glycoprotein isoform expression in benign and malignant human prostate cells by isoform-specific monoclonal antibodies.
Kawai K; Sakurai M; Sakai T; Misaki M; Kusano I; Shiraishi T; Yatani R
Cancer Lett; 2000 Mar; 150(2):147-53. PubMed ID: 10704736
[TBL] [Abstract][Full Text] [Related]
2. Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma?
Ashmore SM; Thomas DG; Darling JL
Anticancer Drugs; 1999 Nov; 10(10):861-72. PubMed ID: 10630353
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies specific for P-glycoprotein.
Okochi E; Iwahashi T; Tsuruo T
Leukemia; 1997 Jul; 11(7):1119-23. PubMed ID: 9205000
[TBL] [Abstract][Full Text] [Related]
4. Determining MDR1/P-glycoprotein expression in breast cancer.
Faneyte IF; Kristel PM; van de Vijver MJ
Int J Cancer; 2001 Jul; 93(1):114-22. PubMed ID: 11391630
[TBL] [Abstract][Full Text] [Related]
5. A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections.
Moran E; Larkin A; Doherty G; Kelehan P; Kennedy S; Clynes M
J Clin Pathol; 1997 Jun; 50(6):465-71. PubMed ID: 9378810
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance P-glycoprotein monoclonal antibody JSB-1 crossreacts with pyruvate carboxylase.
Rao VV; Anthony DC; Piwnica-Worms D
J Histochem Cytochem; 1995 Dec; 43(12):1187-92. PubMed ID: 8537634
[TBL] [Abstract][Full Text] [Related]
7. Detection of the multidrug resistance marker P-glycoprotein by immunohistochemistry in malignant lung tumours.
Beer TW; Rowlands DC; Crocker J
Thorax; 1996 May; 51(5):526-9. PubMed ID: 8711682
[TBL] [Abstract][Full Text] [Related]
8. Isoform I (mdr3) is the major form of P-glycoprotein expressed in mouse brain capillaries. Evidence for cross-reactivity of antibody C219 with an unrelated protein.
Jetté L; Pouliot JF; Murphy GF; Béliveau R
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):761-6. PubMed ID: 7848274
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of P-glycoprotein and expression of the multidrug resistance-1 gene in human pancreatic cancer: relevance to indicator of better prognosis.
Suwa H; Ohshio G; Arao S; Imamura T; Yamaki K; Manabe T; Imamura M; Hiai H; Fukumoto M
Jpn J Cancer Res; 1996 Jun; 87(6):641-9. PubMed ID: 8766529
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
11. Production of monoclonal antibodies to P-glycoprotein: its application in detection of soluble and surface P-glycoprotein of leukemia patients.
Chiampanichayakul S; Anuchapreeda S; Chruewkamlow N; Mahasongkram K; Thanaratanakorn P; Kasinrerk W
Int J Hematol; 2010 Sep; 92(2):326-33. PubMed ID: 20740331
[TBL] [Abstract][Full Text] [Related]
12. Effect of endogenous multidrug resistance 1 and P-glycoprotein expression on anticancer drug resistance in colon cancer cell lines.
Washio I; Nakanishi T; Ishiguro N; Bister B; Tamai I
Biopharm Drug Dispos; 2019 Jan; 40(1):32-43. PubMed ID: 30556139
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of multidrug resistance gene product, P-glycoprotein, in normal, dysplastic and malignant oral mucosa in India.
Jain V; Das SN; Luthra K; Shukla NK; Ralhan R
Int J Cancer; 1997 Feb; 74(1):128-33. PubMed ID: 9036881
[TBL] [Abstract][Full Text] [Related]
14. Expression and functions of P-glycoprotein (mdr1 gene product) in normal and malignant tissues.
Sugawara I
Acta Pathol Jpn; 1990 Aug; 40(8):545-53. PubMed ID: 1978461
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance related molecules in human and murine lung.
Scheffer GL; Pijnenborg AC; Smit EF; Müller M; Postma DS; Timens W; van der Valk P; de Vries EG; Scheper RJ
J Clin Pathol; 2002 May; 55(5):332-9. PubMed ID: 11986335
[TBL] [Abstract][Full Text] [Related]
16. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators.
Charpin C; Vielh P; Duffaud F; Devictor B; Andrac L; Lavaut MN; Allasia C; Horschowski N; Piana L
J Natl Cancer Inst; 1994 Oct; 86(20):1539-45. PubMed ID: 7932810
[TBL] [Abstract][Full Text] [Related]
17. Establishment and evaluation of MRK16-magnetic cell sorting assays for detecting low expression of multidrug resistance P-glycoprotein using human leukemia cell lines and peripheral blood cells from healthy donors.
Okochi E; Iwahashi T; Ariyoshi K; Watabe H; Tsuruo T; Ono K
J Immunol Methods; 1995 Nov; 187(1):127-37. PubMed ID: 7490449
[TBL] [Abstract][Full Text] [Related]
18. Is P-glycoprotein a sufficient marker for multidrug resistance in vivo? Immunohistochemical staining for P-glycoprotein in children and adult leukemia: correlation with clinical outcome.
Kaczorowski S; Ochocka M; Kaczorowska M; Aleksandrowicz R; Matysiakl M; Karwacki M
Leuk Lymphoma; 1995 Dec; 20(1-2):143-52. PubMed ID: 8750636
[TBL] [Abstract][Full Text] [Related]
19. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.
Yamaguchi M; Kita K; Miwa H; Nishii K; Oka K; Ohno T; Shirakawa S; Fukumoto M
Cancer; 1995 Dec; 76(11):2351-6. PubMed ID: 8635042
[TBL] [Abstract][Full Text] [Related]
20. Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse.
Sinicrope FA; Hart J; Brasitus TA; Michelassi F; Lee JJ; Safa AR
Cancer; 1994 Dec; 74(11):2908-17. PubMed ID: 7954255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
